IRX Therapeutics develops immune therapies designed to activate a patient’s immune system to defeat cancer and related diseases. IRX Therapeutics’ is focused on making cancer treatments better. The lead platform technology, IRX-2, is thought to broadly restore the immune system by overcoming cancer-induced immune suppression. The Company believes that its products can play an important role in helping a wide range of cancer treatments improve and extend the lives of patients. It was founded in 1994 and is headquartered in New York.

Anhui Huien Biotechnology Co., Ltd., established on 2013-05-17, Business scope includes cell engineering,Development and sales of detection technology for products related to genetic engineering and protein engineering;cell therapy technology,Development and service of protein therapy and gene detection technology;cell engineering,Technical achievements transfer service of genetic engineering and protein engineering,technical consulting;cell collection,Detection and storage service;Production of cellular cosmetics,Technology development and sales;Research in Biological Sciences and Technology,transfer,Consulting and Services;Development of cell therapy drugs and biomedical technologies;one type,Class II,Research and development of three types of medical devices;Healthy food,Technical development and sales of healthcare products;Conference Services;Biomedical Technology Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Jingmeng Hi-Tech Stem Cell Technology Co., Ltd., established on 2009-08-13, The business scope includes cell engineering and tissue engineering related products,cell therapy technology,cell antibody,Technology development of gene medicine,Technology Promotion,technology transfer,technical consulting;Home remote health management service;Community telehealth management service;sell cosmetics,self-developed products,Instrumentation,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),medical instrumentsIkind;Medical Research and Experimental Development;health management,Health Advisory(Except for medical treatment activities subject to approval);Medical Laboratory;clinical body fluid,blood specialty;clinical microbiology major;clinical chemistry laboratory;clinical immunization,Serology major;Clinical Cytomolecular Genetics Major(Limited to branch operations).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Xingao Tongchuang Technology Co., Ltd., established on 2000-07-20, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Natural science research and experimental development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Part of Zunyi Medical University, Affiliated Hospital of Zunyi Medical College is a company headquartered in Zunyi, China. The firm provides medical services.

Wuxi Huajing Biotechnology Co., Ltd., established on 2015-04-30, The business scope includes lymphocyte separation fluid,Mannose,Development of Bantang Emulsion,Technical Services;Production of lymphocyte separation fluid,Sales;Chemical raw materials,Chemical Products(Free of Hazardous Chemicals)promotion of;Self-operated import and export of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nantong Biaoyuan Biotechnology Co., Ltd., established on 2010-06-08, The business scope includes three categories6840Production of in vitro diagnostic reagents;Research and development of bioengineering and biomedical engineering,Professional technical service,Technology exchange and promotion services;disinfection products,hygiene products,Sales of household chemicals.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Henan Jintai Biotechnology Co., Ltd., established on 2013-08-22, Business scope includes engineering technology research and experimental development;Medical Research and Experimental Development;Biotechnology Extension Services;Health Advisory;Wholesale of medical supplies and equipment;Wholesale of nutrition and health products;Wholesale of cosmetics and hygiene products.

Beijing Histe Medical Laboratory Co., Ltd., established on 2005-08-26, The scope of business includes medical laboratory;clinical body fluid,blood specialty;clinical chemistry laboratory;clinical immunization,Serology major;Clinical Cytomolecular Genetics Major/Pathology(The medical institution practice license is valid until2025year06moon01day);technology development,technology transfer,technical consulting,Technical Services;Sales of chemical products(Does not contain dangerous chemicals and a class of precursor drugs),Instrumentation,Equipment(Cars not included),Class I medical device;Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Medical Laboratory;clinical body fluid,blood specialty;clinical chemistry laboratory;clinical immunization,Serology major;Clinical Cytomolecular Genetics Major/Department of Pathology and programs subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

ImmuQuad Biotechnologies, based in Hangzhou, China, was established in 2016 and has become a leading national high-tech enterprise in the field of immunogenomics technology. The company's founding team hails from the University of Chicago in the United States. Since 2010, they have been utilizing high-throughput sequencing technology to conduct immune profiling in various disease-related research projects. In 2016, they independently developed and introduced the pioneering Seq-MRD® product, the first Next-Generation Sequencing Minimal Residual Disease (NGS-MRD) blood tumor MRD detection solution. This groundbreaking product was subsequently licensed to Genetron Health (NASDAQ: GTH). ImmuQuad also offers a range of other products and services, including Immun-Traq® for tumor treatment companion diagnostics, Immun-Cheq® for T-cell immune evaluation, and ImmuHub® for immunogenomic sequencing research services. Moreover, the company has established platforms like T-classifier®, which employs AI machine learning algorithms for disease early screening, single-cell sequencing, and TCR-T drug development. With a robust intellectual property portfolio consisting of numerous invention patents and software copyrights, ImmuQuad provides solutions and products for clinical hospitals, life science research, and new drug development. ImmuQuad is committed to decoding the adaptive immune system and actively advancing the development of immunology-driven medicine to revolutionize disease diagnosis and treatment.

Jilin Jienzhihe Biotherapy Technology Co., Ltd., established on 2018-12-29, Business scope includes precision medical technology,technology development in biotechnology,Achievement transfer;Research on Cell Engineering and Cell Expansion Technology,to develop;stem cell,Immune Cells,Technical development of genetic engineering and related products,technology transfer,Technical Advisory Services;Cell Diagnosis Technology,cell therapy technology,Biotechnology,Technical research and development of laboratory equipment technology and related products,Technology Promotion,technology transfer,technical consulting,Technical Services;Research on immune cells and stem cell storage technology,to develop,technical consulting,technology transfer;Research and development of cell therapy-related reagents and medical devices,Production,Sales;Immune Cell and Stem Cell Storage Services;Medical enterprise management service;Biological product,biomedicine,biomaterials,biotechnology products,Health products,Class I medical device,R&D of cosmetics,Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is an American company located in New York, NY. The firm operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer. NTN Buzztime, Inc. acquired Eterna Therapeutics LLC on March 25, 2021 for $213.30 million.\nThe company says this about itself: Brooklyn is exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. The company is also exploring opportunities to advance oncology and blood disorder therapies using leading edge gene editing/cell therapy technology through the newly acquired license from Factor Bioscience and Novellus. Brooklyn’s most advanced program is studying the safety and efficacy of IRX-2 in patients with head and neck cancer. In a Phase 2A clinical trial in head and neck cancer, IRX-2 demonstrated an overall survival benefit. Additional studies are either underway or planned in other solid tumor cancer indications.

Boya Stem Cell Technology Co. Ltd. develops stem cell technology products. The company is headquartered in Wuxi, China.

Jilin Aoweizi Biomedical Engineering Co., Ltd., established on 2017-05-04, The scope of business includes technology research and development in the field of bioscience and technology,consult,Technical Services;R&D of medical devices,Sales,Beauty Technology Development,technical consulting,Technical Services,Beauty product research and development,Sales,Carry out stem cell collection within the scope stipulated by the Ministry of Health,Production of stem cell preparations,Clinical application of stem cell transplantation technology and production of tissue engineering products,Immune Cell Technology Services,Research and development of biotechnology,Consulting and Assignment,R & D and sales of scientific research equipment,Cosmetics Wholesale,Sales,Acquisition of agricultural by-products,Pharmaceutical Sales,R&D and sales of biologics,electronic product,Wholesale and retail of communication products,Health Advisory,Pension Service,Real estate development and management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Shanghai Zion Biotechnology Co., Ltd., established on 1995-11-23, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Sales of Class I Medical Devices;Class I Medical Device Leasing;Instrument sales;Smart Instrument Sales;electronics sales;Home Appliance Sales;Office Supplies Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangzhou Boren Ankang Medical Technology Co., Ltd., established on 2016-07-26, The scope of business includes the operation of licensed medical devices;medical diagnosis,Monitoring and treatment equipment retail;medical diagnosis,Monitoring and treatment equipment wholesale;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Medical equipment rental service;Commodity wholesale trade(Except for licensed and approved products);Office equipment rental service;Technology Import and Export;Biotechnology Consulting,communication service;Cold storage rental service;Commodity retail trade(Except for licensed and approved products);Instrument wholesale;Chemical Product Retail(Excluding hazardous chemicals);Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated);Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals);Operation of non-licensed medical devices;drug development;Forestry scientific research service;Wholesale of safety technology and prevention products;Import and export(Excluding franchised products);Biotechnology Development Services;Wholesale of cosmetics and hygiene products;Retailing of cosmetics and hygiene products;Medical supplies and equipment retail(Does not contain drugs and medical devices);Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals);

Zhejiang Litongde Hospital is a Chinese private company located in Hangzhou. The firm provides healthcare services.

Jiangsu Maijian Biotechnology Development Co., Ltd. is a private company headquartered in Wuxi, China. The firm wholesales cosmetics products.

Shengzhi Runhe (Beijing) Biotechnology Co., Ltd., established on 2021-08-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Human stem cell technology development and application;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Natural science research and experimental development;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Production of Class III Medical Devices;Production of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Tianjin Presell Biotechnology Co., Ltd., established on 2015-10-22, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Human stem cell technology development and application;Project planning and public relations services;Sales of Class I Medical Devices;software development;data processing services.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)